| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.
|
N Engl J Med
|
2007
|
12.17
|
|
2
|
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
|
J Infect Dis
|
2009
|
5.09
|
|
3
|
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
|
J Natl Cancer Inst
|
2010
|
4.20
|
|
4
|
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
|
J Infect Dis
|
2009
|
3.55
|
|
5
|
Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
|
BMJ
|
2010
|
3.41
|
|
6
|
Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials.
|
Lancet
|
2007
|
3.10
|
|
7
|
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (Types 6/11/16/18) vaccine against high-grade cervical and external genital lesions.
|
Cancer Prev Res (Phila)
|
2009
|
2.42
|
|
8
|
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine.
|
Vaccine
|
2008
|
2.09
|
|
9
|
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.74
|
|
10
|
Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection.
|
Hum Vaccin
|
2009
|
1.66
|
|
11
|
To butterfly or to needle: the pilot phase.
|
Ann Intern Med
|
2004
|
1.40
|
|
12
|
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.34
|
|
13
|
Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer.
|
Clin Cancer Res
|
2006
|
1.24
|
|
14
|
The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells.
|
Breast Cancer Res Treat
|
2007
|
1.23
|
|
15
|
Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women.
|
Clin Cancer Res
|
2005
|
1.23
|
|
16
|
Characterization of benign and malignant breast lesions with computed tomography laser mammography (CTLM): initial experience.
|
Invest Radiol
|
2005
|
1.10
|
|
17
|
CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia.
|
Breast Cancer Res Treat
|
2004
|
1.06
|
|
18
|
An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer.
|
Cancer Res
|
2003
|
1.02
|
|
19
|
Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
|
Cancer
|
2004
|
0.99
|
|
20
|
Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
|
Clin Cancer Res
|
2002
|
0.99
|
|
21
|
HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.
|
Oncol Rep
|
2005
|
0.93
|
|
22
|
Phytoestrogens in clinical practice: a review of the literature.
|
Fertil Steril
|
2007
|
0.93
|
|
23
|
Comparison of p53 mutational status with mRNA and protein expression in a panel of 24 human breast carcinoma cell lines.
|
Breast Cancer Res Treat
|
2003
|
0.92
|
|
24
|
Expression of MUC1 splice variants in benign and malignant ovarian tumours.
|
Int J Cancer
|
2002
|
0.92
|
|
25
|
Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters.
|
Anticancer Res
|
2003
|
0.91
|
|
26
|
Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis.
|
Gynecol Oncol
|
2005
|
0.89
|
|
27
|
Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer.
|
Gynecol Oncol
|
2002
|
0.88
|
|
28
|
Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women.
|
Breast Cancer Res Treat
|
2002
|
0.88
|
|
29
|
Genetic alterations in endometrial hyperplasia and cancer.
|
Cancer Lett
|
2002
|
0.87
|
|
30
|
A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis.
|
Gynecol Oncol
|
2004
|
0.87
|
|
31
|
Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia.
|
Gynecol Oncol
|
2011
|
0.87
|
|
32
|
A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the prognosis of patients with ovarian cancer.
|
Gynecol Oncol
|
2005
|
0.86
|
|
33
|
Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
|
Int J Oncol
|
2003
|
0.86
|
|
34
|
The urethra during pelvic floor contraction: observations on three-dimensional ultrasound.
|
Obstet Gynecol
|
2002
|
0.86
|
|
35
|
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines.
|
Clin Vaccine Immunol
|
2007
|
0.86
|
|
36
|
Malignant fibrous histiocytoma (MFH) of the mesentery: a case report.
|
Anticancer Res
|
2002
|
0.86
|
|
37
|
Polymorphisms of the interleukin-1 gene cluster and ovarian cancer.
|
J Soc Gynecol Investig
|
2002
|
0.85
|
|
38
|
Expression of thrombospondin 1 (TSP 1) in patients with uterine smooth muscle tumors: an immunohistochemical study.
|
Gynecol Oncol
|
2006
|
0.82
|
|
39
|
Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast.
|
Oncol Rep
|
2003
|
0.82
|
|
40
|
Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy.
|
Anticancer Res
|
2003
|
0.82
|
|
41
|
Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.
|
J Reprod Med
|
2003
|
0.81
|
|
42
|
Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology.
|
Int J Gynecol Cancer
|
2009
|
0.81
|
|
43
|
Expression of the human MTA1 gene in breast cell lines and in breast cancer tissues.
|
Oncol Res
|
2007
|
0.80
|
|
44
|
Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer.
|
Gynecol Oncol
|
2004
|
0.80
|
|
45
|
Expression of MUCI splice variants correlates with invasive growth of breast cancer cell lines.
|
Breast Cancer Res Treat
|
2002
|
0.80
|
|
46
|
Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
|
Gynecol Oncol
|
2005
|
0.80
|
|
47
|
Vascular endothelial growth factor (VEGF) and discrimination between abnormal intrauterine and ectopic pregnancy.
|
Hum Reprod
|
2002
|
0.78
|
|
48
|
Bcl-2 expression in a primary leiomyosarcoma of the ovary: a case report.
|
Wien Klin Wochenschr
|
2003
|
0.77
|
|
49
|
Squamous cell carcinoma antigen serum levels as prognostic parameter in patients with early stage vulvar cancer.
|
Gynecol Oncol
|
2005
|
0.77
|
|
50
|
Serum levels of squamous cell carcinoma antigen as a predictor of inguinofemoral lymph node metastasis in patients with vulvar cancer.
|
J Reprod Med
|
2002
|
0.76
|
|
51
|
Prognostic value of laminin-5 in serous adenocarcinomas of the ovary.
|
Anticancer Res
|
2003
|
0.75
|
|
52
|
[Anterior sacral meningocele in pregnancy].
|
Wien Klin Wochenschr
|
2003
|
0.75
|
|
53
|
Christian Doppler and the influence of his work on modern medicine.
|
Wien Klin Wochenschr
|
2004
|
0.75
|
|
54
|
A common polymorphism within the steroid 5-alpha-reductase type 2 gene and timing of menopause in Caucasian women.
|
Eur J Obstet Gynecol Reprod Biol
|
2005
|
0.75
|
|
55
|
Loss of heterozygosity on chromosome 13q: suggestion of a candidate tumor suppressor gene in sporadic breast cancer.
|
Breast Cancer Res Treat
|
2004
|
0.75
|
|
56
|
Prevalence of human papillomavirus types 6, 11, 16 and 18 in young Austrian women - baseline data of a phase III vaccine trial.
|
Wien Klin Wochenschr
|
2008
|
0.75
|
|
57
|
The influence of a Vitamin D receptor gene polymorphism on the timing of female reproductive functions in humans.
|
Maturitas
|
2005
|
0.75
|
|
58
|
Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients.
|
Oncol Rep
|
2003
|
0.75
|